Dror Harats

This inventor holds 31 USPTO granted patents and 13 published patent applications, plus 4 CIPO patents and 11 EPO patents, primarily in Pharmaceutical Innovation. Top assignees: Vascular Biogenics Ltd., Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.. Active years: 1998-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dror Harats. Retrieved from https://idiyas.com/inventor/dror-harats

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 (Patent Applications = 13)

% Patents Active = 48.4

CIPO Patents = 4

EPO Patents = 11 (Patent Applications = 15)

Average Co-Inventor Count = 3.2

ph-index = 14

Forward Citations = 392(Granted Patents)

Location History:

Ramat Ran, IL (2007)
Ramat-Gan, IL (1998 - 2015)

Company Filing History:

24 out of 46

Vascular Biogenics Ltd.

patents

6 out of 10

Nikken Sohonsha Corporation

patents

6 out of 131

Tel Hashomer Medical Research Infrastructure and Services Ltd.

where one patent can have more than one assignee

Years Active: 1998-2015

Loading Chart...

Areas of Expertise:

Psoriasis Treatment

Retinitis Pigmentosa

Angiogenesis

Pharmaceutical Compositions

Endothelial Cell Specificity

Oxidized Phospholipids

Atherosclerosis

Inflammatory Diseases

Gene Expression

Targeted Therapy

Polynucleotide Constructs

Ophthalmic Disorders

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9180152 - Method for treating psoriasis (2015-11-10),

2. 8961993 - Method of treating retinitis pigmentosa (2015-02-24),

3. 8916378 - Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapy (2014-12-23),

4. 8859747 - Promoters exhibiting endothelial cell specificity and methods of using same (2014-10-14),

5. 8859745 - Promoters exhibiting endothelial cell specificity and methods of using same (2014-10-14),

6. 8846401 - Promoters exhibiting endothelial cell specificity and methods of using same (2014-09-30),

7. 8835398 - Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis (2014-09-16),

8. 8563534 - Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis (2013-10-22),

9. 8529907 - Methods of treating ophthalmic disorders (2013-09-10),

10. 8501715 - Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders (2013-08-06),

11. 8415318 - Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy (2013-04-09),

12. 8343549 - [object Object] (2013-01-01),

13. 8206743 - Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis (2012-06-26),

14. 8158611 - Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis (2012-04-17),

15. 8071740 - Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis (2011-12-06),

Title: Inventor Spotlight: Dror Harats Shaping the Future in Medical Treatment

Introduction:

Dror Harats, a prolific inventor based in Ramat-Gan, IL, is making significant strides in the field of medical treatment with his groundbreaking patented innovations. With an impressive portfolio of 31 patents and a focus on improving the lives of those suffering from conditions like psoriasis and retinal diseases, Dror Harats is a pioneer in the healthcare industry.

Latest Patents:

Among Dror Harats' latest patents is a method for treating psoriasis, which involves orally administering a pharmaceutically-effective amount of crude powder to subjects with the condition. Additionally, his method for treating retinitis pigmentosa aims to enhance day and night vision in individuals with retinal diseases through the administration of a pharmaceutical composition containing crude powder.

Career Highlights:

Having worked with renowned companies such as Vascular Biogenics Ltd. and Nikken Sohonsha Corporation, Dror Harats has honed his skills and expertise in the medical technology sector. His innovative approach to treating complex medical conditions has garnered him recognition as a leading figure in the industry.

Collaborations:

Throughout his career, Dror Harats has collaborated with esteemed professionals in the field, including Eyal Breitbart and Jacob George. These collaborations have resulted in the development of cutting-edge solutions that have the potential to revolutionize the healthcare landscape.

Conclusion:

In conclusion, Dror Harats' dedication to advancing medical treatment through innovation and inventive solutions is reshaping the way we approach healthcare. With a strong focus on improving the quality of life for individuals suffering from various medical conditions, Dror Harats continues to push the boundaries of what is possible in the field of medical technology.

Profile summary based on public USPTO records.